HONIGBERG LEE has a total of 38 patent applications. Its first patent ever was published in 2008. It filed its patents most often in United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are UFPEPTIDES S R L, XIMMUNE AB and GLAXO WELLCOME MFG PTE LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 38 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Honigberg Lee | 38 |
#2 | Verner Erik | 26 |
#3 | Pan Zhengying | 22 |
#4 | Chen Wei | 16 |
#5 | Buggy Joseph J | 14 |
#6 | Loury David J | 12 |
#7 | Verner Erik J | 12 |
#8 | Loury David | 4 |
#9 | Buggy Joseph | 2 |
#10 | Mody Tarak D | 1 |
Publication | Filing date | Title |
---|---|---|
US2012178753A1 | Inhibitors of Bruton's tyrosine kinase | |
US2012065201A1 | Inhibitors of bruton's tyrosine kinase |